YARROW BIOSCIENCE, INC.(YARW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

YARW YARROW BIOSCIENCE, INC.

交易中 08-24 09:57:02 EDT

38.28

+1.85

+5.08%

最高38.28	最低38.28	成交量1,248
今开38.28	昨收36.43	日振幅0.00%
总市值1.02亿	流通市值2,341万	总股本266.98万
成交额4.70万	换手率0.20%	流通股本61.15万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"YARW","market":"US","secType":"STK","nameCN":"YARROW BIOSCIENCE, INC.","latestPrice":38.275,"timestamp":1787579780483,"preClose":36.425,"halted":0,"volume":1248,"delay":0,"changeRate":0.05078929306794788,"floatShares":611500,"shares":2669800,"eps":-21.86,"marketStatus":"交易中","change":1.85,"latestTime":"08-24 09:57:02 EDT","open":38.275,"high":38.275,"low":38.275,"amount":46989.50131199999,"amplitude":0,"askPrice":39.11,"askSize":98,"bidPrice":36.42,"bidSize":22,"shortable":3,"etf":0,"ttmEps":-21.86,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"listingDate":1516856400000,"exchange":"NASDAQ","adjPreClose":36.425,"preHourTrading":{"tag":"盘前","latestPrice":36.01,"preClose":36.425,"latestTime":"09:09 EDT","volume":1,"amount":36.01,"timestamp":1787576978553,"change":-0.415,"changeRate":-0.011393,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.425,"preClose":36.425,"latestTime":"19:30 EDT","volume":10,"amount":369.5,"timestamp":1787355005444,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.758302},"requestUrl":"/m/hq/s/YARW","defaultTab":"news","newsList":[{"id":"2654045362","title":"Yarrow Bioscience完成与VYNE合并，Graves病药物YB-101启动II期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2654045362","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654045362?lang=zh_cn&edition=full","pubTime":"2026-07-27 21:56","pubTimestamp":1785160560,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Yarrow Bioscience今日宣布，已完成与VYNE Therapeutics的合并，并同步完成约2亿美元私募融资。合并后公司将继续以Yarrow Bioscience名义运营，其普通股预计于7月28日在纳斯达克资本市场挂牌交易，股票代码为“YARW”。目前，YB-101已启动针对GD患者的IIa/IIb期临床试验，并获得美国FDA快速通道认定，IIa期数据预计于2027年下半年读出。Yarrow计划在获得IIa期数据后，于2028年上半年启动约200例患者的IIb剂量探索阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-27/doc-inikhiss8341457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["YARW","VYNE","BK4007","BK4173","YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150755970","title":"Vyne Therapeutics 更新现金分红、反向拆股及与 Yarrow Bioscience 拟议合并交割预期时间安排","url":"https://stock-news.laohu8.com/highlight/detail?id=1150755970","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150755970?lang=zh_cn&edition=full","pubTime":"2026-07-24 04:36","pubTimestamp":1784838975,"startTime":"0","endTime":"0","summary":"Vyne Therapeutics 发布了最新公告。该公告涉及现金分红、反向拆股，以及其与 Yarrow Bioscience 拟议合并的预期交割时间。这一系列关键事项的最新进展，现已向市场公开。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","YARW","VYNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118603468","title":"VYNE Therapeutics宣布1比50反向拆股 并就与Yarrow Bioscience拟议合并相关的特别股息提供最新信息","url":"https://stock-news.laohu8.com/highlight/detail?id=1118603468","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118603468?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:01","pubTimestamp":1784635272,"startTime":"0","endTime":"0","summary":"VYNE Therapeutics Inc. 宣布，公司将实施1比50的反向股票拆分，并提供了与拟议中的Yarrow Bioscience合并案相关的特别股息的最新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","YARW","VYNE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.yarrowbioscience.com","stockEarnings":[{"period":"1week","weight":-0.1427},{"period":"1month","weight":-0.1884},{"period":"3month","weight":0.085},{"period":"6month","weight":0.2248},{"period":"1year","weight":1.2568},{"period":"ytd","weight":0.2558}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Yarrow Bioscience, Inc.于2011年10月作为特拉华州的一家公司注册成立。该公司是一家临床阶段的生物制药公司，专注于开发差异化疗法，以治疗存在高度未满足医疗需求的炎症性和免疫介导性疾病。Yarrow的专有BET抑制剂（构成其InhiBET平台）旨在通过利用替代给药途径和增强选择性来克服早期BET抑制剂的局限性。该公司也专注于开发自身免疫性甲状腺疾病的疗法，包括一种潜在的首创抗促甲状腺激素受体单克隆抗体，该抗体旨在直接破坏格雷夫斯病和甲状腺眼病的中心机制。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.037101},{"month":2,"riseRate":0.444444,"avgChangeRate":0.014686},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.004341},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.154087},{"month":5,"riseRate":0.555556,"avgChangeRate":0.00572},{"month":6,"riseRate":0.111111,"avgChangeRate":-0.050475},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.128315},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.071725},{"month":9,"riseRate":0.5,"avgChangeRate":-0.023153},{"month":10,"riseRate":0.5,"avgChangeRate":0.011012},{"month":11,"riseRate":0.5,"avgChangeRate":-0.029442},{"month":12,"riseRate":0.375,"avgChangeRate":-0.029662}],"exchange":"NASDAQ","name":"YARROW BIOSCIENCE, INC.","nameEN":"YARROW BIOSCIENCE, INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"YARROW BIOSCIENCE, INC.(YARW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供YARROW BIOSCIENCE, INC.(YARW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"YARROW BIOSCIENCE, INC.,YARW,YARROW BIOSCIENCE, INC.股票,YARROW BIOSCIENCE, INC.股票老虎,YARROW BIOSCIENCE, INC.股票老虎国际,YARROW BIOSCIENCE, INC.行情,YARROW BIOSCIENCE, INC.股票行情,YARROW BIOSCIENCE, INC.股价,YARROW BIOSCIENCE, INC.股市,YARROW BIOSCIENCE, INC.股票价格,YARROW BIOSCIENCE, INC.股票交易,YARROW BIOSCIENCE, INC.股票购买,YARROW BIOSCIENCE, INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"YARROW BIOSCIENCE, INC.(YARW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供YARROW BIOSCIENCE, INC.(YARW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}